SCHEMBL360234

SCHEMBL360234

N#Cc1cc2nc(N)sc2cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.49
GFER P55789 1/20 0.49
CYP3A4 P08684 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 3/20 0.47
TP53 P04637 2/20 0.47
TSHR P16473 1/20 0.47
LMNA P02545 3/20 0.45
DRD2 P14416 2/20 0.43
SCN4A P35499 3/20 0.41
EPHX2 P34913 1/20 0.41
RAB9A P51151 4/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP2C9 P11712 2/20 0.40
KHK P50053 1/20 0.40
NPC1 O15118 3/20 0.39
CYP1A2 P05177 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20570918 0.93 AXL (0.49) AXLGFERCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL361030 0.80 KHK (0.40) KHKKMT2A
SCHEMBL25604312 0.80 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1TP53RAB9AGAA
SCHEMBL210148 0.80 AXL (0.60) AXLGFERCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL29801372 0.80 AXL (0.60) AXLGFERCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL5679365 0.80 SCN4A (0.49) AXLGFERCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL25607091 0.77 CYP11B2 (0.39) CYP3A4ALDH1A1LMNACYP2C9KHK
SCHEMBL360416 0.74 CA2 (0.41) SMN1; SMN2ALDH1A1RAB9AKHKNPC1
SCHEMBL26189895 0.74 MAOB (0.40) MAPT
SCHEMBL19709634 0.74 AXL (0.53) AXLGFERCYP3A4SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007510-A1 COMPOUNDS FOR BINDING AND IMAGING AMYLOID PLAQUES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-01-19 WO disclosed